Cargando…

Effectiveness of early heparin therapy on outcomes in critically ill patients with sepsis-induced coagulopathy

Background: This study aimed to investigate whether early unfractionated heparin (UFH) administration provides a survival advantage for patients with sepsis-induced coagulopathy (SIC). Methods: Patients hospitalized with sepsis-induced coagulopathy from the Medical Information Mart for Intensive Car...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Jia-Jia, Zou, Zhi-Ye, Zhou, Zhi-Peng, Liu, Yan, Yang, Zhen-Jia, Zhang, Jing-Jing, Luan, Ying-Yi, Yao, Yong-Ming, Wu, Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10225678/
https://www.ncbi.nlm.nih.gov/pubmed/37256226
http://dx.doi.org/10.3389/fphar.2023.1173893
_version_ 1785050427319910400
author Huang, Jia-Jia
Zou, Zhi-Ye
Zhou, Zhi-Peng
Liu, Yan
Yang, Zhen-Jia
Zhang, Jing-Jing
Luan, Ying-Yi
Yao, Yong-Ming
Wu, Ming
author_facet Huang, Jia-Jia
Zou, Zhi-Ye
Zhou, Zhi-Peng
Liu, Yan
Yang, Zhen-Jia
Zhang, Jing-Jing
Luan, Ying-Yi
Yao, Yong-Ming
Wu, Ming
author_sort Huang, Jia-Jia
collection PubMed
description Background: This study aimed to investigate whether early unfractionated heparin (UFH) administration provides a survival advantage for patients with sepsis-induced coagulopathy (SIC). Methods: Patients hospitalized with sepsis-induced coagulopathy from the Medical Information Mart for Intensive Care (MIMIC)-IV database were identified. Patients were divided into two groups, who received unfractionated heparin (UFH) subcutaneously within 24 h after intensive care unit (ICU) admission, and the control group, who received not. The primary endpoint was intensive care unit mortality, the secondary outcomes were 7, 14, and 28-day and hospital mortality. Propensity score matching (PSM) the marginal structural Cox model (MSCM) and E-value analysis were used to account for baseline differences, time-varying and unmeasured confounding factors. Results: A total of 3,377 patients with sepsis-induced coagulopathy were enrolled in the study, of which 815 in unfractionated heparin group and 2,562 in control group. There was significant effect on primary and secondary outcomes with unfractionated heparin after propensity score matching (intensive care unit mortality, hazard ratio [HR] 0.69, 95% confidence interval [CI] 0.52–0.92; 7-day, HR 0.70, 95% CI 0.49–0.99; 14-day, HR 0.68.95% CI 0.50–0.92; 28-day, HR 0.72, 95% CI 0.54–0.96; hospital mortality, HR 0.74, 95% CI 0.57–0.96), marginal structural Cox model manifested unfractionated heparin associated with decreased intensive care unit mortality in all populations (HR 0.64, 95% CI 0.49–0.84), and stratification with the marginal structural Cox model indicated analysis further indicated the survival advantage only among patients with an sepsis-induced coagulopathy score of 4 (HR 0.56, 95% CI 0.38–0.81). Further analysis showed that treatment with 6,250–13750 IU/day of unfractionated heparin associated with a decreased risk of intensive care unit mortality. Similar results were replicated in subgroup analysis with propensity score matching only for patients with an sepsis-induced coagulopathy score of 4 (intensive care unit mortality, HR 0.51, 95% CI 0.34–0.76). Conclusion: This study found early unfractionated heparin therapy to patients with sepsis-induced coagulopathy appears to be associated with improved outcomes. Subgroup analysis further demonstrates heparin therapy decreased intensive care unit mortality primarily in patients only with SIC score of 4.
format Online
Article
Text
id pubmed-10225678
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-102256782023-05-30 Effectiveness of early heparin therapy on outcomes in critically ill patients with sepsis-induced coagulopathy Huang, Jia-Jia Zou, Zhi-Ye Zhou, Zhi-Peng Liu, Yan Yang, Zhen-Jia Zhang, Jing-Jing Luan, Ying-Yi Yao, Yong-Ming Wu, Ming Front Pharmacol Pharmacology Background: This study aimed to investigate whether early unfractionated heparin (UFH) administration provides a survival advantage for patients with sepsis-induced coagulopathy (SIC). Methods: Patients hospitalized with sepsis-induced coagulopathy from the Medical Information Mart for Intensive Care (MIMIC)-IV database were identified. Patients were divided into two groups, who received unfractionated heparin (UFH) subcutaneously within 24 h after intensive care unit (ICU) admission, and the control group, who received not. The primary endpoint was intensive care unit mortality, the secondary outcomes were 7, 14, and 28-day and hospital mortality. Propensity score matching (PSM) the marginal structural Cox model (MSCM) and E-value analysis were used to account for baseline differences, time-varying and unmeasured confounding factors. Results: A total of 3,377 patients with sepsis-induced coagulopathy were enrolled in the study, of which 815 in unfractionated heparin group and 2,562 in control group. There was significant effect on primary and secondary outcomes with unfractionated heparin after propensity score matching (intensive care unit mortality, hazard ratio [HR] 0.69, 95% confidence interval [CI] 0.52–0.92; 7-day, HR 0.70, 95% CI 0.49–0.99; 14-day, HR 0.68.95% CI 0.50–0.92; 28-day, HR 0.72, 95% CI 0.54–0.96; hospital mortality, HR 0.74, 95% CI 0.57–0.96), marginal structural Cox model manifested unfractionated heparin associated with decreased intensive care unit mortality in all populations (HR 0.64, 95% CI 0.49–0.84), and stratification with the marginal structural Cox model indicated analysis further indicated the survival advantage only among patients with an sepsis-induced coagulopathy score of 4 (HR 0.56, 95% CI 0.38–0.81). Further analysis showed that treatment with 6,250–13750 IU/day of unfractionated heparin associated with a decreased risk of intensive care unit mortality. Similar results were replicated in subgroup analysis with propensity score matching only for patients with an sepsis-induced coagulopathy score of 4 (intensive care unit mortality, HR 0.51, 95% CI 0.34–0.76). Conclusion: This study found early unfractionated heparin therapy to patients with sepsis-induced coagulopathy appears to be associated with improved outcomes. Subgroup analysis further demonstrates heparin therapy decreased intensive care unit mortality primarily in patients only with SIC score of 4. Frontiers Media S.A. 2023-05-15 /pmc/articles/PMC10225678/ /pubmed/37256226 http://dx.doi.org/10.3389/fphar.2023.1173893 Text en Copyright © 2023 Huang, Zou, Zhou, Liu, Yang, Zhang, Luan, Yao and Wu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Huang, Jia-Jia
Zou, Zhi-Ye
Zhou, Zhi-Peng
Liu, Yan
Yang, Zhen-Jia
Zhang, Jing-Jing
Luan, Ying-Yi
Yao, Yong-Ming
Wu, Ming
Effectiveness of early heparin therapy on outcomes in critically ill patients with sepsis-induced coagulopathy
title Effectiveness of early heparin therapy on outcomes in critically ill patients with sepsis-induced coagulopathy
title_full Effectiveness of early heparin therapy on outcomes in critically ill patients with sepsis-induced coagulopathy
title_fullStr Effectiveness of early heparin therapy on outcomes in critically ill patients with sepsis-induced coagulopathy
title_full_unstemmed Effectiveness of early heparin therapy on outcomes in critically ill patients with sepsis-induced coagulopathy
title_short Effectiveness of early heparin therapy on outcomes in critically ill patients with sepsis-induced coagulopathy
title_sort effectiveness of early heparin therapy on outcomes in critically ill patients with sepsis-induced coagulopathy
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10225678/
https://www.ncbi.nlm.nih.gov/pubmed/37256226
http://dx.doi.org/10.3389/fphar.2023.1173893
work_keys_str_mv AT huangjiajia effectivenessofearlyheparintherapyonoutcomesincriticallyillpatientswithsepsisinducedcoagulopathy
AT zouzhiye effectivenessofearlyheparintherapyonoutcomesincriticallyillpatientswithsepsisinducedcoagulopathy
AT zhouzhipeng effectivenessofearlyheparintherapyonoutcomesincriticallyillpatientswithsepsisinducedcoagulopathy
AT liuyan effectivenessofearlyheparintherapyonoutcomesincriticallyillpatientswithsepsisinducedcoagulopathy
AT yangzhenjia effectivenessofearlyheparintherapyonoutcomesincriticallyillpatientswithsepsisinducedcoagulopathy
AT zhangjingjing effectivenessofearlyheparintherapyonoutcomesincriticallyillpatientswithsepsisinducedcoagulopathy
AT luanyingyi effectivenessofearlyheparintherapyonoutcomesincriticallyillpatientswithsepsisinducedcoagulopathy
AT yaoyongming effectivenessofearlyheparintherapyonoutcomesincriticallyillpatientswithsepsisinducedcoagulopathy
AT wuming effectivenessofearlyheparintherapyonoutcomesincriticallyillpatientswithsepsisinducedcoagulopathy